ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kyowa Kirin Receives Partial Change Approval for ORKEDIA in Japan
December 22, 2019The approval is based on the result of the Phase 3 clinical trial that evaluates the efficacy of ORKEDIA for hypercalcemia in patients with parathyroid carcinoma or primary hyperparathyroidism who are unable to undergo parathyroidectomy or relapse after p -
Kyowa Kirin gets FDA nod for Parkinson’s drug
September 04, 2019Kyowa Kirin Announces FDA Approval of NOURIANZTM (istradefylline) for Use in Parkinson’s Disease -
Kyowa Kirin buys back Tivozanib rights from AVEO oncology
August 04, 2019Kyowa Kirin will reobtain the non-oncology rights of tivozanib in AVEO territories excluding the rights which are currently sublicensed to EUSA Pharma -
EU approves Kyowa Kirin’s drug for rare lymphoma
November 30, 2018The European Commission has approved Poteligeo (mogamulizumab), a treatment for rare types of non-Hodgkin’s lymphoma.
Pharma Sources Insight January 2025
